Join to View Full Profile
301 University BlvdGalveston, TX 77555
Phone+1 409-772-0090
Dr. Laposata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Laposata is a pathologist in Galveston, TX and is affiliated with University of Texas Medical Branch. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 41 years. He specializes in clinical pathology. He has more than 180 publications and over 1000 citings.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1983 - 1985
Johns Hopkins University School of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 2016 - 2025
TN State Medical License 2008 - 2016
MA State Medical License 1989 - 2010
PA State Medical License 1986 - 1990
American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 2 citationsImpact of diagnostic management team on patient time to diagnosis and percent of accurate and clinically actionable diagnoses.Jessica Brashear, Ryan Mize, Michael Laposata, Christopher Zahner
Diagnosis. 2024-05-01 - Collaboration to Improve Emergency Laboratory Response: Open letter from the Open letter from the Association of Pathology Chairs to the Centers for Disease Control & ...Lydia Pleotis Howell, Michael Laposata, Priscilla S Markwood
Academic Pathology. 2024-02-05 - 3 citationsIntracellular receptor EPAC regulates von Willebrand factor secretion from endothelial cells in a PI3K-/eNOS-dependent manner during inflammation.Jie Xiao, Ben Zhang, Zhengchen Su, Yakun Liu, Thomas R. Shelite
The Journal of Biological Chemistry. 2021-10-20
Press Mentions
Association for Molecular Pathology Applauds U.S. District Court’s Ruling to Overturn FDA Regulation on Laboratory-Developed TestsMarch 31st, 2025- U.S. District Court Vacates FDA LDT Final RuleFebruary 28th, 2025
- A Space Waiting to Be FilledNovember 22nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
